| 5080 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, September 21, 2009 |
null |
| endorsement | 0.464042 |
| small printing plant | 0.548812 |
| current awareness | 0.476587 |
| findings | 0.426451 |
| Family history | 0.478328 |
| respondent-driven sampling | 0.481473 |
| Disease Control | 0.477544 |
| CDC Knowledge | 0.662408 |
| methylene chloride | 0.492654 |
| supervised-injection facilities | 0.483082 |
| Action Science Clips | 0.920361 |
| factual accuracy | 0.476481 |
| new weekly digest | 0.568508 |
| Evaluation | 0.423048 |
| local coalitions | 0.487856 |
| Chief Science Officer | 0.562811 |
| article | 0.421076 |
| DHHS | 0.494641 |
| Brief report | 0.482586 |
| public domain | 0.487736 |
| Stephen B. Thacker | 0.709741 |
| biologic markers | 0.488085 |
| black women | 0.478083 |
| items | 0.430389 |
| community ownership | 0.480846 |
|
| community members | 0.482381 |
| Maximizing Independence | 0.481355 |
| health study | 0.479772 |
| current epidemiology | 0.482955 |
| Alzheimer | 0.429995 |
| national review | 0.483888 |
| COSHH essentials | 0.489522 |
| views | 0.424141 |
| informational purposes | 0.470326 |
| public health literature | 0.544388 |
| breast cancer | 0.474776 |
| B. Thacker CDC | 0.819043 |
| sex partner recruitment | 0.547301 |
| U.S. population | 0.480761 |
| original authors | 0.477107 |
| opinion | 0.420941 |
| STI risk | 0.484697 |
| non-CDC Websites | 0.475804 |
| cognitive health | 0.483519 |
| original sources | 0.486959 |
| news sources | 0.477657 |
| home-based exercise program | 0.546739 |
| Thacker CDC Library | 0.818927 |
| acetone exposures | 0.492254 |
|
CLICK HERE |
| 5996 |
Centers for Disease Control and Prevention |
Html |
en |
Sodium aluminum fluoride (as F) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6023 |
Centers for Disease Control and Prevention |
Html |
en |
Nitrobenzene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7543 |
Centers for Disease Control and Prevention |
Html |
en |
ADHD - Symptoms and Diagnosis |
ADHD is one of the most common neurobehavioral disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD have trouble paying attention, controlling impulsive behaviors (may act without thinking about what the result will be), and in some cases, are overly active. |
| American Academy | 0.37038 |
| mental health | 0.484906 |
| mobile telephones | 0.348631 |
| Inattentive Presentation | 0.334613 |
| school materials | 0.349662 |
| different settings | 0.361801 |
| similar symptoms | 0.418543 |
| long period | 0.352293 |
| older ages | 0.347772 |
| health care providers | 0.484715 |
| National Institutes | 0.334633 |
| dissociative disorder | 0.345616 |
| hyperactive-impulsive symptoms | 0.381972 |
| mood disorder | 0.342515 |
| mental effort | 0.347542 |
| personality disorder | 0.339234 |
| several-step process | 0.382106 |
| developmental level | 0.498554 |
| diagnostic standard | 0.353763 |
| adolescents age | 0.350908 |
| close attention | 0.341184 |
| symptoms | 0.801823 |
| certain types | 0.369321 |
| primary care provider | 0.511588 |
|
| single test | 0.375385 |
| leisure activities | 0.357864 |
| anxiety disorder | 0.337736 |
| Predominantly Hyperactive-Impulsive Presentation | 0.443578 |
| child | 0.345047 |
| ADHD | 0.683411 |
| criteria inattention | 0.44656 |
| American Psychiatric Association | 0.938588 |
| adults | 0.383792 |
| daily activities | 0.365035 |
| health professional | 0.358968 |
| inattention | 0.494759 |
| healthcare professionals | 0.490402 |
| his/her turn | 0.347155 |
| public health | 0.359863 |
| National Resource Center | 0.456955 |
| sleep disorders | 0.364114 |
| younger children | 0.339661 |
| careless mistakes | 0.356451 |
| Statistical Manual | 0.501374 |
| mental disorder | 0.345454 |
| psychotic disorder | 0.345434 |
| activities | 0.429764 |
| Mental Disorders | 0.33893 |
|
CLICK HERE |
| 8899 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - About Malaria - Facts |
Facts about malaria in the United States, Worldwide, prevention and treatment, and biology, pathology and epidemiology. |
| experienced laboratory technician | 0.432037 |
| South America | 0.370994 |
| infected blood cells | 0.439695 |
| P. malariae | 0.429646 |
| Anopheles quadrimaculatus | 0.398394 |
| Charles Louis Alphonse | 0.435857 |
| antimalarial drugs | 0.374139 |
| malaria infection | 0.547065 |
| World Health Organization | 0.438084 |
| Julius Wagner-Jauregg | 0.372248 |
| reference diagnostic tools | 0.429171 |
| clinical episodes | 0.372023 |
| local mosquitoes | 0.387864 |
| Paul Hermann Müller | 0.439771 |
| Nobel Prize | 0.368442 |
| Pregnant women | 0.37276 |
| malaria-endemic countries | 0.446996 |
| P. ovale | 0.428584 |
| malaria parasites | 0.58607 |
| United States | 0.784039 |
| recent travelers | 0.385203 |
| endemic areas | 0.379072 |
| An. freeborni | 0.377634 |
| Cinchona spp. | 0.383844 |
| malaria | 0.90284 |
|
| 17th century | 0.368833 |
| transmitted mosquito-borne malaria | 0.656385 |
| P. vivax | 0.463242 |
| 40-year high | 0.387465 |
| Artemisia annua | 0.378159 |
| local residents | 0.378726 |
| Anopheles mosquitoes | 0.399443 |
| cinchona tree | 0.383904 |
| U.S./Mexico border | 0.382915 |
| An. pseudopunctipennis | 0.377513 |
| Qinghaosu plant | 0.371355 |
| malaria prevention measures | 0.652172 |
| Sir Ronald Ross | 0.425728 |
| transfusion-transmitted malaria | 0.573098 |
| symptomless intervals | 0.375114 |
| infect humans | 0.373453 |
| P. falciparum malaria | 0.683198 |
| second-generation immigrants | 0.38515 |
| constant risk | 0.376549 |
| dormant liver stages | 0.434624 |
| P. knowlesi | 0.391629 |
| malaria cases | 0.593819 |
| Youyou Tu | 0.372815 |
| malaria transmission | 0.643451 |
|
CLICK HERE |
| 10088 |
Centers for Disease Control and Prevention |
Html |
en |
Vital Signs Telebriefing on Restraint Use and Motor Vehicle Occupant Death Rates Among Children Aged 0-12 Years, United States, 2002-2011 | Transcript | CDC Newsroom | CDC |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| child seat law | 0.333621 |
| car seat | 0.671974 |
| maggie fox | 0.300792 |
| booster seat | 0.514492 |
| child passenger restraint | 0.336077 |
| jessica bliss | 0.378016 |
| children | 0.505305 |
| Health care providers | 0.328526 |
| sized car seat | 0.315264 |
| children occupant deaths | 0.300095 |
| motor vehicle fatalities | 0.298062 |
| tom frieden | 0.802398 |
| mike stobbe | 0.610765 |
| booster seats | 0.401657 |
| car seats | 0.404618 |
| Brian | 0.290708 |
| certified child safety | 0.29541 |
| appropriate car seat | 0.326684 |
| motor vehicle occupant | 0.340215 |
| child | 0.550987 |
| child passenger | 0.54548 |
| Vital Signs | 0.35597 |
| line | 0.317633 |
| child fatalities | 0.343144 |
| exact denominator data | 0.333903 |
|
| car seat distribution | 0.332806 |
| passenger restraint laws | 0.324965 |
| convertible car seat | 0.315181 |
| state child passenger | 0.294294 |
| child passenger restraints | 0.293182 |
| motor vehicle | 0.680087 |
| states | 0.349592 |
| certified child passenger | 0.334952 |
| erin sauber-schatz | 0.923181 |
| child passenger deaths | 0.368252 |
| Dr. Tom Frieden | 0.341413 |
| vehicle occupant deaths | 0.299916 |
| child passenger safety | 0.514245 |
| question | 0.360489 |
| Dr. Erin Sauber-Schatz | 0.416145 |
| motor vehicle deaths | 0.294408 |
| Tennessee newspaper | 0.309145 |
| appropriate car seats | 0.299936 |
| tom skinner | 0.81584 |
| seat belt | 0.302198 |
| OPERATOR | 0.338833 |
| motor vehicle crashes | 0.669884 |
| Dr. Frieden | 0.347637 |
| past decade | 0.32158 |
|
CLICK HERE |
| 12430 |
Centers for Disease Control and Prevention |
Html |
en |
Measles | Complications | CDC |
null |
| Miller E. | 0.440645 |
| Internationally Adopted Child | 0.429891 |
| Causing SSPE | 0.382586 |
| Subacute Sclerosing Panencephalitis | 0.972081 |
| Bonthius DJ | 0.370354 |
| MedlinePlus Medical Encyclopedia | 0.437158 |
| Vaccine Preventable Diseases | 0.445727 |
| Disease Control | 0.43603 |
| children | 0.388257 |
| pregnant woman | 0.379378 |
| Emerg Infect Dis. | 0.572987 |
| young children | 0.387038 |
| Brown KE | 0.37363 |
| measles virus | 0.806263 |
| Measles Virus Strains | 0.693883 |
| Measles. 8th Edition | 0.371197 |
| Farrington CP | 0.376853 |
| measles vaccination | 0.626333 |
| child deaf | 0.377652 |
| age groups | 0.391978 |
| diarrhea | 0.337621 |
| severe complications | 0.392099 |
| K. The Epidemiology | 0.384844 |
| C. Subacute Sclerosing | 0.561557 |
| Wild-type Measles Virus | 0.708911 |
|
| Int J Epidemiol. | 0.454708 |
| intellectual disability | 0.380894 |
| Lowe L.E. | 0.374106 |
| United States | 0.433949 |
| measles complications | 0.824907 |
| Measles chapter | 0.658317 |
| Measles Immunization | 0.634628 |
| Miller E. Review | 0.43171 |
| Prevention | 0.350494 |
| low-birth-weight baby | 0.380028 |
| Vaccine-Preventable Diseases | 0.374152 |
| Common measles complications | 0.783339 |
| Miller E. Characterization | 0.432611 |
| Barrero PR | 0.37371 |
| common cause | 0.376439 |
| permanent hearing loss | 0.458093 |
| Brown DWG | 0.373419 |
| Brain Tissue | 0.37261 |
| people | 0.340006 |
| SSPE | 0.40405 |
| Pink Book | 0.377053 |
| et al | 0.371847 |
| ear infections | 0.475056 |
| measles | 0.928652 |
|
CLICK HERE |
| 12856 |
Centers for Disease Control and Prevention |
Html |
en |
Transmission of Hepatitis C Virus Associated with SurgicalProcedures - New Jersey 2010 and Wisconsin 2011 |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| infection prevention training | 0.25764 |
| HCV infections | 0.657999 |
| patient A. Propofol | 0.271649 |
| maximum likelihood dendrogram | 0.25351 |
| perfusion machine | 0.37975 |
| surgical procedures | 0.432691 |
| quasispecies analysis | 0.258292 |
| acid amplification test | 0.367207 |
| kidney perfusion machine | 0.319534 |
| intensive care unit | 0.275165 |
| nucleic acid amplification | 0.368437 |
| health care encounters | 0.261226 |
| HCV genotype | 0.390389 |
| operating room | 0.267436 |
| chronic HCV infection | 0.621244 |
| test results | 0.26046 |
| basic infection control | 0.256509 |
| HCV testing protocol | 0.430368 |
| patients | 0.344056 |
| operating rooms | 0.258026 |
| HCV contamination | 0.412532 |
| time reversible model | 0.255891 |
| injection safety | 0.277766 |
| HCV strains | 0.507124 |
| acute HCV infections | 0.532134 |
|
| chronic renal disease | 0.284201 |
| HCV RNA | 0.447902 |
| HCV infection | 0.972623 |
| infection prevention practices | 0.455039 |
| infection control | 0.336735 |
| positive HCV enzyme | 0.440912 |
| Routine HCV antibody | 0.426581 |
| inpatient dialysis unit | 0.264449 |
| HCV enzyme | 0.448373 |
| HCV antibody test | 0.434082 |
| health care | 0.563302 |
| public health | 0.456067 |
| infection control practices | 0.271195 |
| New Jersey Department | 0.29623 |
| HCV transmission | 0.767309 |
| HCV-4 infection | 0.270516 |
| female health care | 0.265278 |
| surgical intensive care | 0.287975 |
| New Jersey | 0.483523 |
| different viral sequence | 0.255791 |
| HVR1 quasispecies sequences | 0.257926 |
| unique sequence patterns | 0.255187 |
| chronic HCV infections | 0.564712 |
| health care transmission | 0.310346 |
|
CLICK HERE |
| 13090 |
Centers for Disease Control and Prevention |
Html |
en |
Groups at Higher Risk for BRCA Gene Mutations |
Certain family history patterns indicate a higher risk for a BRCA1 or BRCA2 gene mutation. |
| higher risk | 0.599726 |
| list Skip | 0.448846 |
| ovarian cancer | 0.709703 |
| abdomen | 0.323549 |
| page options Skip | 0.535966 |
| ovarian cancers | 0.55465 |
| breast cancer | 0.90639 |
| Eastern European | 0.47614 |
| Central | 0.335305 |
| BRCA1 | 0.335566 |
| Male breast cancer | 0.553097 |
| Certain family history | 0.48041 |
|
| family member | 0.382967 |
| relatives | 0.375573 |
| navigation Skip | 0.447701 |
| breasts | 0.324448 |
| Ashkenazi Jewish ancestry | 0.647938 |
| Triple-negative breast cancer | 0.559126 |
| family history includes— | 0.468186 |
| BRCA2 mutation | 0.435381 |
| BRCA2 gene mutation | 0.532395 |
| BRCA gene mutation | 0.682544 |
| fallopian tube cancer | 0.464077 |
|
CLICK HERE |
| 15812 |
Centers for Disease Control and Prevention |
Html |
en |
Raccoon Roundworm Infection Associated with Central NervousSystem Disease and Ocular Disease - Six States, 2013-2015 |MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| human baylisascariasis cases | 0.367467 |
| residual neurologic sequelae | 0.382603 |
| pet raccoon | 0.368874 |
| previous Baylisascaris infection | 0.528245 |
| eosinophilic meningitis | 0.386841 |
| Baylisascaris procyonis antibody | 0.703975 |
| Baylisascaris infections | 0.490387 |
| Baylisascaris procyonis | 0.984099 |
| Baylisascaris immunoblot assay | 0.492434 |
| fatal human disease | 0.41182 |
| CSF samples | 0.432871 |
| Baylisascaris ocular larva | 0.585635 |
| raccoon feces | 0.429982 |
| larva migrans | 0.536975 |
| raccoon latrines | 0.429301 |
| raccoon exposure | 0.402874 |
| serum sample | 0.367869 |
| specific raccoon exposure | 0.380011 |
| Baylisascaris procyonis eggs | 0.676356 |
| patients | 0.373941 |
| ocular larva migrans | 0.521337 |
| history | 0.371185 |
| altered mental status | 0.396628 |
| clinical presentation | 0.389524 |
|
| Baylisascaris neural larva | 0.52406 |
| CSF eosinophilia | 0.387067 |
| CSF sample | 0.381298 |
| Baylisascaris procyonis prevention | 0.609137 |
| geographic distribution | 0.383936 |
| United States | 0.487852 |
| visceral larva migrans | 0.38612 |
| Baylisascaris serologic testing | 0.518417 |
| CSF analysis | 0.384025 |
| neural larva migrans | 0.518026 |
| patient | 0.374419 |
| CSF | 0.493774 |
| severe neurologic deficits | 0.420818 |
| elevated CSF eosinophil | 0.409085 |
| persistent neurologic deficits | 0.41535 |
| neurologic deficits | 0.43463 |
| raccoons | 0.457349 |
| positive antibody test | 0.372222 |
| Baylisascaris hosts | 0.465893 |
| Baylisascaris procyonis infections | 0.666385 |
| clinical suspicion | 0.385869 |
| infectious Baylisascaris procyonis | 0.63847 |
| severe neurologic outcomes | 0.368145 |
| CSF testing | 0.393388 |
|
CLICK HERE |